Holen Sie sich die Stockscreener-App
64.50
2.46%
1.55
Handel nachbörslich:
64.50
Schlusskurs vom Vortag:
$62.95
Offen:
$62.26
24-Stunden-Volumen:
421.84K
Relative Volume:
1.34
Marktkapitalisierung:
$1.92B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-16.29
EPS:
-3.9598
Netto-Cashflow:
$-74.38M
1W Leistung:
-0.60%
1M Leistung:
+3.12%
6M Leistung:
+56.36%
1J Leistung:
+13.16%
1-Tages-Spanne:
$61.07
$65.14
1-Wochen-Bereich:
$61.07
$67.87
52-Wochen-Spanne:
$25.60
$77.60
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
64.50 | 1.92B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by State Street Corp - Defense World
Disc Medicine (NASDAQ:IRON) Stock Price Down 3%Should You Sell? - MarketBeat
Disc medicine CEO sells shares worth $844,314 By Investing.com - Investing.com Australia
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells $844,333.91 in Stock - MarketBeat
Disc medicine CEO sells shares worth $844,314 - Investing.com
Disc Medicine's SWOT analysis: rare blood disorder stock poised for growth - Investing.com
Y Intercept Hong Kong Ltd Takes Position in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
(IRON) Technical Data - Stock Traders Daily
Disc Medicine's SWOT analysis: stock potential amid mixed trial results - Investing.com
Disc Medicine's SWOT analysis: stock potential amid mixed trial results By Investing.com - Investing.com Canada
Fmr LLC Has $19.99 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Wellington Management Group LLP - MarketBeat
Verition Fund Management LLC Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Charles Schwab Investment Management Inc. Purchases 19,401 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) Target Price at $85.80 - MarketBeat
Disc Medicine (NASDAQ:IRON) Given Outperform Rating at Wedbush - Defense World
Disc Medicine Presents Positive Clinical and Translational - GlobeNewswire
Disc Medicine Unveils Breakthrough Clinical Results for Blood Disorder Portfolio at ASH 2024 - StockTitan
Disc Medicine (NASDAQ:IRON) Earns "Buy" Rating from HC Wainwright - MarketBeat
Disc Medicine's Myelofibrosis Drug Shows Breakthrough Results in Phase 1b Trial with 100% Response Rate - StockTitan
Disc Medicine Presents Positive Updated Results from Phase - GlobeNewswire
Janus Henderson Group PLC Raises Position in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Intech Investment Management LLC Buys New Shares in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine director White sells $126k in stock By Investing.com - Investing.com Nigeria
Disc Medicine director White sells $126k in stock - Investing.com India
HighVista Strategies LLC Invests $470,000 in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
S&P GS Excess Index (G7N22) Quote - The Globe and Mail
DJ Brent Crude Index (BBR) QuotePress Release - The Globe and Mail
Walleye Capital LLC Boosts Stake in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Ally Bridge Group NY LLC Has $4.91 Million Stake in Disc Medicine, Inc. (NASDAQ:IRON) - MarketBeat
Disc Medicine maintains Buy rating with $111 target By Investing.com - Investing.com Canada
Disc Medicine chief medical officer sells $928k in stock - Investing.com India
Disc Medicine chief medical officer sells $928k in stock By Investing.com - Investing.com Nigeria
Disc Medicine, Inc. (NASDAQ:IRON) Holdings Trimmed by Eagle Asset Management Inc. - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Victory Capital Management Inc. - MarketBeat
Disc Medicine secures $200m financing to support trials - MSN
Contrasting Pharming Group (OTCMKTS:PHGUF) and Disc Medicine (NASDAQ:IRON) - Defense World
Disc Medicine chief medical officer sells $546,152 in stock - Investing.com
Disc Medicine chief medical officer sells $546,152 in stock By Investing.com - Investing.com Canada
Disc Medicine Announces New Equity Sales Agreement - TipRanks
Cantor Fitzgerald Predicts Disc Medicine FY2024 Earnings - Defense World
FY2024 EPS Estimates for Disc Medicine Raised by Analyst - MarketBeat
Wedbush Forecasts Disc Medicine's Q4 Earnings (NASDAQ:IRON) - MarketBeat
Disc Medicine FY2024 EPS Estimate Raised by Leerink Partnrs - MarketBeat
Lifesci Capital Predicts Stronger Earnings for Disc Medicine - MarketBeat
Disc Medicine FY2024 EPS Forecast Boosted by HC Wainwright - MarketBeat
Paradigm Biocapital Advisors LP Adjusts Stake in Disc Medicine I - GuruFocus.com
Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) PT at $85.80 - MarketBeat
FY2028 Earnings Forecast for Disc Medicine Issued By Wedbush - MarketBeat
Disc Medicine Inc. (IRON) Quarterly 10-Q Report - Quartz
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Quisel John D | Chief Executive Officer |
Dec 16 '24 |
Sale |
66.01 |
12,791 |
844,314 |
72,065 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):